Adjusting for treatment effects in studies of quantitative traits: Antihypertensive therapy and systolic blood pressure

Statistics in Medicine

Volumn 24, Issue 19, 2005, Pages 2911-2935

  Tobin, Martin D ^a   Sheehan, Nuala A ^a   Scurrah, Katrina J ^a   Burton, Paul R ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Blood pressure; Epidemiology; Population based; Quantitative traits; Treatment effects

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ACCURACY; ANALYTIC METHOD; ANTIHYPERTENSIVE THERAPY; ARTICLE; BIOSTATISTICS; PHENOTYPE; POPULATION RESEARCH; QUANTITATIVE TRAIT; REGRESSION ANALYSIS; SIMULATION; STATISTICAL ANALYSIS; STATISTICAL MODEL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

AGED; ANTIHYPERTENSIVE AGENTS; BIAS (EPIDEMIOLOGY); BLOOD PRESSURE; COMPUTER SIMULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, GENETIC; MODELS, STATISTICAL; QUANTITATIVE TRAIT, HERITABLE;

EID: 26444496137     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.2165     Document Type: Article

References (45)

1. Williams RR, Rao DC, Ellison RC, Arnett DK, Heiss G, Oberman A, Eckfeldt JH, Leppert MF, Province MA, Mockrin SC, Hunt SC. NHLBI family blood pressure program: methodology and recruitment in the HyperGEN network. Hypertension genetic epidemiology network. Annals of Epidemiology 2000; 10(6):389-400.
2. Harrap SB, Stebbing M, Hopper JL, Hoang HN, Giles GG. Familial patterns of covariation for cardiovascular risk factors in adults: the Victorian family heart study. American Journal of Epidemiology 2000; 152(8): 704-715.
3. Sagnella GA, Rothwell MJ, Onipinla AK, Wicks PD, Cook DG, Cappuccio FP. A population study of ethnic variations in the angiotensin-converting enzyme I/D polymorphism: relationships with gender, hypertension and impaired glucose metabolism. Journal of Hypertension 1999; 17(5):657-664.
4. Levy D, DeStefano AL, Larson MG, O'Donnell CJ, Lifton RP, Gavras H, Cupples LA, Myers RH. Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study. Hypertension 2000; 36(4):477-483.
5. Hunt SC, Ellison RC, Atwood LD, Pankow JS, Province MA, Leppert MF. Genorne scans for blood pressure and hypertension: the National Heart, Lung, and Blood Institute family heart study. Hypertension 2002; 40(1):1-6.
6. Pereira AC, Mota GF, Cunha RS, Herbenhoff FL, Mill JG, Krieger JE. Angiotensinogen 235T allele 'dosage' is associated with blood pressure phenotypes. Hypertension 2003; 41(1):25-30.
7. Brand E, Wang JG, Herrmann SM, Staessen JA. An epidemiological study of blood pressure and metabolic phenotypes in relation to the Gbeta3 C825T polymorphism. Journal of Hypertension 2003; 21(4):729-737.
8. Iwai N, Baba S, Mannami T, Katsuya T, Higaki J, Ogihara T, Ogata J. Association of sodium channel gamma-subunit promoter variant with blood pressure. Hypertension 2001; 38(1):86-89.
9. Cui JS, Hopper JL, Harrap SB. Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension 2003; 41(2):207-210.
10. White IR, Chaturvedi N, McKeigue PM. Median analysis of blood pressure for a sample including treated hypertensives. Statistics in Medicine 1994; 13(16):1635-1641.
11. Matsubara M, Kikuya M, Ohkubo T, Metoki H, Omori F, Fujiwara T, Suzuki M, Michimata M, Hozawa A, Katsuya T, Higaki J, Tsuji I, Araki T, Ogihara T, Satoh H, Hisamichi S, Nagai K, Kitaoka H, Imai Y. Aldosterone synthase gene (CYP11B2) C-334T polymorphism, ambulatory blood pressure and nocturnal decline in blood pressure in the general Japanese population: the Ohasama Study. Journal of Hypertension 2001; 19(12):2179-2184.
12. Schunkert H, Hense HW, Doring A, Riegger GA, Siffert W. Association between a polymorphism in the G protein beta3 subunit gene and lower renin and elevated diastolic blood pressure levels. Hypertension 1998; 32(3):510-513.
13. Sethi AA, Nordestgaard BG, Tybjaerg-Hansen A. Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arteriosclerosis Thrombosis and Vascular Biology 2003; 23(7):1269-1275.
14. Rice T, Rankinen T, Province MA, Chagnon YC, Perusse L, Borecki IB, Bouchard C, Rao DC. Genome-wide linkage analysis of systolic and diastolic blood pressure: the Quebec family study. Circulation 2000; 102(16):1956-1963.
15. O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Myers RH, Levy D. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham heart study. Circulation 1998; 97(18):1766-1772.
16. Sethi AA, Nordestgaard BG, Agerholm-Larsen B, Frandsen E, Jensen G, Tybjaerg-Hansen A. Angiotensinogen polymorphisms and elevated blood pressure in the general population: the Copenhagen city heart study. Hypertension 2001; 37(3):875-881.
17. Zhu X, Chang YP, Yan D, Weder A, Cooper R, Luke A, Kan D, Chakravarti A. Associations between hypertension and genes in the renin-angiotensin system. Hypertension 2003; 41(5):1027-1034.
18. Little JRA, Rubin DB. Statistical Analysis with Missing Data. Wiley: New York, 1987.
19. Rubin DB. Inference and missing data. Biometrika 1976; 63:581-592.
20. Cook NR. An imputation method for non-ignorable missing data in studies of blood pressure. Statistics in Medicine 1997; 16(23):2713-2728.
21. Rubin DB. Multiple Imputation for Non-response in Surveys. Wiley: New York, 1987.
22. Schafer JL. Analysis of Incomplete Multivariate Data. Chapman & Hall: London, 1997.
23. Cui J, Hopper JL, Harrap SB. Genes and family environment explain correlations between blood pressure and body mass index. Hypertension 2002; 40(1):7-12.
24. White IR, Koupilova I, Carpenter J. The use of regression models for medians when observed outcomes may be modified by interventions. Statistics in Medicine 2003; 22(7):1083-1096.
25. Tobin J. Estimation of relationships for limited dependent variables. Econometrica 1958; 26(1):24-36.
26. Hasstedt SJ. Variance components/major locus likelihood approximation for quantitative, polychotomous, and multivariate data. Genetic Epidemiology 1993; 10(3):145-158.
27. Atwood LD, Samollow PB, Hixson JE, Stern MP, MacCluer JW. Genome-wide linkage analysis of blood pressure in Mexican Americans. Genetic Epidemiology 2001; 20(3):373-382.
28. Clayton D, Hills M. Statistical Models in Epidemiology. Oxford University Press: Oxford, 1993.
29. Lowe GD, Yarnell JW, Rumley A, Bainton D, Sweetnam PM. C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis? Arteriosclerosis Thrombosis and Vascular Biology 2001; 21(4):603-610.
30. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361(9360):865-872.
31. Cardon LR, Bell JI. Association study designs for complex diseases. Nature Reviews Genetics 2001; 2(2): 91-99.
32. Mancia G, Sega R, Grassi G, Cesana G, Zanchetti A. Defining ambulatory and home blood pressure normality: further considerations based on data from the PAMELA study. Journal of Hypertension 2001; 19(6):995-999.
33. Sega R, Corrao G, Bombelli M, Beltrame L, Facchetti R, Grassi G, Ferrario M, Mancia G. Blood pressure variability and organ damage in a general population: results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). Hypertension 2002; 39(2 Part 2):710-714.
34. Sever P, Beevers G, Bulpitt C, Lever A, Ramsay L, Reid J, Swales J. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. British Medical Journal 1993; 306(6883):983-987.
35. The Stationery Office. The Health Survey for England 1998: Cardiovascular Disease. The Stationery Office: London, 1999.
36. Ramsay L, Williams B, Johnston G, MacGregor G, Poston L, Potter J, Poulter N, Russell G. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. Journal of Human Hypertension 1999; 13(9):569-592.
37. Cappuccio FP, Cook DG, Atkinson RW, Strazzullo P. Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London. Heart 1997; 78(6):555-563.
38. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. Journal of the American Medical Association 2003; 289(18):2363-2369.
39. Stata Corporation. Stata User's Guide. Version 7.0. Stata Press: College Station, TX, 2001.
40. The Caerphilly and Speedwell Collaborative Group. Caerphilly and Speedwell collaborative heart disease studies. Journal of Epidemiology and Community Health 1984; 38(3):259-262.
41. Tobin MD. The genetic epidemiology of blood pressure in human populations. PhD Thesis, University of Leicester, Leicester, 2004.
42. Neaton JD, Grimm Jr RH, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, Cutler JA, Flack JM, Schoenberger JA, McDonald R et al. Treatment of mild hypertension study. Final results. Treatment of Mild Hypertension Study Research Group. Journal of the American Medical Association 1993; 270(6):713-724.
43. Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. British Medical Journal 2003; 326(7404):1427.
44. Spiegelhalter D, Thomas A, Best N. WinBUGS Version 1.3 - User Manual. MRC Biostatistics Unit: Cambridge, 2000.
45. Burton PR, Tiller KJ, Gurrin LC, Cookson WO, Musk AW, Palmer LJ. Genetic variance components analysis for binary phenotypes using generalized linear mixed models (GLMMs) and Gibbs sampling. Genetic Epidemiology 1999; 17(2):118-140.